Skip to main content
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1995 May;87(5):359–362.

Beyond controlling blood pressure in the black patient: metabolic considerations.

J F Burris 1
PMCID: PMC2607791  PMID: 7783244

Abstract

Hypertension is highly prevalent among African Americans, who are also more likely than whites to develop end-organ complications of hypertension. Traditional diuretic-based stepcare therapy has successfully reduced such complications of hypertension as stroke, congestive heart failure, and premature death in all populations tested. Prevention of coronary deaths has been less successful. Potentially adverse metabolic effects of thiazide diuretics and some beta-blockers may partially explain the less successful cardiac outcomes. Use of antihypertensive agents lacking adverse metabolic effects but still achieving effective blood pressure control could improve cardiac outcomes while maintaining the benefits achieved with older forms of therapy. Achievement of improved cardiac outcomes is now one of the principal goals of hypertension research and treatment.

Full text

PDF
359

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Applegate W. B. Hypertension in elderly patients. Ann Intern Med. 1989 Jun 1;110(11):901–915. doi: 10.7326/0003-4819-110-11-901. [DOI] [PubMed] [Google Scholar]
  2. Burris J. F. Beta-blockers, dyslipidemia, and coronary artery disease. A reassessment. Arch Intern Med. 1993 Sep 27;153(18):2085–2092. [PubMed] [Google Scholar]
  3. Cruickshank J. M., Thorp J. M., Zacharias F. J. Benefits and potential harm of lowering high blood pressure. Lancet. 1987 Mar 14;1(8533):581–584. doi: 10.1016/s0140-6736(87)90231-5. [DOI] [PubMed] [Google Scholar]
  4. Freis E. D. Critique of the clinical importance of diurectic-induced hypokalemia and elevated cholesterol level. Arch Intern Med. 1989 Dec;149(12):2640–2648. [PubMed] [Google Scholar]
  5. Pool J. L. Effects of doxazosin on serum lipids: a review of the clinical data and molecular basis for altered lipid metabolism. Am Heart J. 1991 Jan;121(1 Pt 2):251–260. doi: 10.1016/0002-8703(91)90853-a. [DOI] [PubMed] [Google Scholar]
  6. Saunders E., Weir M. R., Kong B. W., Hollifield J., Gray J., Vertes V., Sowers J. R., Zemel M. B., Curry C., Schoenberger J. A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med. 1990 Aug;150(8):1707–1713. [PubMed] [Google Scholar]
  7. Siscovick D. S., Raghunathan T. E., Psaty B. M., Koepsell T. D., Wicklund K. G., Lin X., Cobb L., Rautaharju P. M., Copass M. K., Wagner E. H. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med. 1994 Jun 30;330(26):1852–1857. doi: 10.1056/NEJM199406303302603. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES